Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy selections remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We've https://financefeeds.com/21x-taps-philip-filhol-for-business-development-ahead-of-exchange-launch/